A randomized, investigator‐blinded efficacy assessment study of stand‐alone emollient use in mild to moderately severe atopic dermatitis flares

Abstract

The results of the study indicate that the 1-week stand-alone application of an emollient, tailored to target inflammation, pruritus, compromised barrier function and pathogenic bacterial colonization may offer benefit for the improvement of mild to moderately severe localized flares of AD.